Synthesis of NIR‐II Fluorescent Hybrid Ag2S/ZnPc Nanoparticles for in vitro Photodynamic Therapy
Source abstract
Abstract
Abstract Fluorescence imaging‐guided photodynamic therapy (PDT), particularly near infrared II (NIR‐II) fluorescence featuring deep penetration depth, can greatly improve the treatment outcomes with precise administration. In this work, a reprecipitation‐encapsulation method was used to co‐load NIR‐II fluorescent Ag2S quantum dots (QDs) and photosensitizer zinc phthalocyanine (ZnPc) into single nanoparticles (NPs), i. e., Ag2S/ZnPc NPs. Moreover, the resultant NPs were coated by a poly‐L‐lysine (PLL) layer, which endowed the initial hydrophobic Ag2S QDs and ZnPc with good biocompatibility. Ag2S/ZnPc NPs exhibited a hydrodynamic diameter of ∼70 nm, strong NIR‐II fluorescence peaking at 1052 nm, efficient cellular uptaken, and high singlet oxygen generation. Taking advantage of Ag2S/ZnPc NPs, efficient phototherapeutic efficacy was achieved on HeLa cells upon the irradiation of 660 nm light, and a deep optical tissue penetration depth of 1.4 mm was obtained under 808 nm excitation. These results suggested that the facilely prepared Ag2S/ZnPc NPs are very promising for NIR‐II fluorescence imaging‐guided in vivo PDT.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Science Minzu University of China Beijing 100081 China
Key Laboratory of Luminescence and Optical Information Ministry of Education Institute of Optoelectronic Technology Beijing Jiaotong University Beijing 100044 China
Funding
National Natural Science Foundation of China
References (46)
Show source-provided references
1. 10.1021/cr400532z10.1021/cr400532z ↗
2. 10.1038/s12276-021-00599-710.1038/s12276-021-00599-7 ↗
3. 10.1002/advs.20210258710.1002/advs.202102587 ↗
4. 10.1021/acs.jmedchem.7b0068210.1021/acs.jmedchem.7b00682 ↗
5. 10.1039/C6DT01929C10.1039/C6DT01929C ↗
6. 10.1039/c4dt00197d10.1039/c4dt00197d ↗
7. 10.1016/j.pdpdt.2018.06.00310.1016/j.pdpdt.2018.06.003 ↗
8. 10.1016/j.materresbull.2019.02.02010.1016/j.materresbull.2019.02.020 ↗
9.
10. 10.1002/ppsc.20130018910.1002/ppsc.201300189 ↗
11. 10.1016/j.jconrel.2021.09.02410.1016/j.jconrel.2021.09.024 ↗
12.
13. 10.3390/nano1105129310.3390/nano11051293 ↗
14. Liu Y. · Adv. Sci. · 2022 · 1010.1002/advs.202203669 ↗
15. 10.1562/2006-04-14-IR-87410.1562/2006-04-14-IR-874 ↗
16.
17. 10.1039/C9NR05733A10.1039/C9NR05733A ↗
18. 10.1002/anie.20110836010.1002/anie.201108360 ↗
19. 10.1002/ange.20110836010.1002/ange.201108360 ↗
20.
21. 10.1021/acs.analchem.9b0415610.1021/acs.analchem.9b04156 ↗
22. 10.1038/nm.299510.1038/nm.2995 ↗
23. 10.1038/nmat447610.1038/nmat4476 ↗
24. 10.1038/nphoton.2014.16610.1038/nphoton.2014.166 ↗
25. 10.1002/ange.20150747310.1002/ange.201507473 ↗
26. 10.1002/anie.20150747310.1002/anie.201507473 ↗
27. 10.1002/anie.20140742010.1002/anie.201407420 ↗
28. 10.1002/ange.20140742010.1002/ange.201407420 ↗
29. 10.1002/adfm.20190056610.1002/adfm.201900566 ↗
30.
31. 10.1002/hc.2146710.1002/hc.21467 ↗
32. 10.1021/acs.bioconjchem.9b0008810.1021/acs.bioconjchem.9b00088 ↗
33. 10.1016/j.nantod.2021.10112010.1016/j.nantod.2021.101120 ↗
34.
35. 10.1186/s12951-020-0572-110.1186/s12951-020-0572-1 ↗
36. 10.1039/C9SC02674F10.1039/C9SC02674F ↗
37.
38. 10.1039/C4RA06098A10.1039/C4RA06098A ↗
39. Sun J. · Acta Pharm. Sin. · 2020 · 12 · 1699
40. 10.1002/etc.562017041110.1002/etc.5620170411 ↗
41. 10.1002/anie.20200094710.1002/anie.202000947 ↗
42. 10.1002/ange.20200094710.1002/ange.202000947 ↗
43. 10.1002/adom.20210023310.1002/adom.202100233 ↗
44. 10.1039/C6TB00307A10.1039/C6TB00307A ↗
45. 10.1021/jp501266d10.1021/jp501266d ↗
46. 10.1002/smll.20200100310.1002/smll.202001003 ↗